Article
A rapid diagnosis pathway for colorectal cancer at the H.U.B
Teams from the Gastroenterology and Digestive Oncology Departments of the Erasmus Hospital and Jules Bordet Institute are now working hand-in-hand within the Brussels University Hospital (H.U.B).  They propose a rapid diagnosis pathway reserved for patients showing warning signs, a positive result in a search for blood in the stools or who are at high risk.  On 22 and 23 March a giant colon will be installed in the lobbies of the Erasmus Hospital and Jules Bordet Institute. Professionals from our institutions will be there on the day to help you discover this organ and highlight the importance of screening for colorectal cancer.     Essential screening   Every year more than 8,000 Belgians, both men and women, are diagnosed with colorectal cancer. In 90% of cases they are aged over 50. One third of these persons will die from their cancer due to a late diagnosis. If detected in time, 90% of these persons are cured.  Faced with this problem, our professionals decided to put into place a rapid diagnosis pathway for patients presenting a warning sign or a high risk.  Colonoscopy screening is essential as it reduces the risk of developing colorectal cancer and reduces the mortality by 50%. This examination has therapeutic as well as diagnostic benefits as it not only allows a cancer to be detected at an early stage but also prevents its occurrence by removing colorectal polyps and early cancers.    Who is the screening targeting?   You can make an appointment with our professionals who will rapidly schedule a colonoscopy if you present warning signs such as an unexplained and lasting change in bowel movements, the presence of blood in the stools, abdominal pain or unexplained weight loss. If you have a personal or family history of polyps and/or colorectal cancer, inflammatory diseases of the digestive tube (Crohn's disease or proctocolitis) or a family history of multiple polyposis or hereditary colon cancer you will be prioritised.    With or without warning signs, from the age of 50 you can also undergo a simple test for the presence of blood in the stools, carried out in your own home following an invitation sent by the Region.    Do you show any of these symptoms? Then make an appointment with our specialists who will schedule your tests as quickly as possible on the basis of your symptoms.    Gastroenterology consultation: • Jules Bordet Institute 02 541 34 80 • Erasmus 02 555 35 04  Screening consultation at the Jules Bordet Institute (if no symptoms): 02 541 30 00   A giant colon to boost awareness   March is awareness month for colorectal cancers. On this occasion the Brussels University Hospital invites you to come and discover a giant colon. Accompanied by health professionals you can actually go inside the structure to discover this organ, in 3D, and better understand why and how to protect yourself against colorectal cancer, one of the most deadly cancers in Belgium.  The dates are 22 March at the Erasmus Hospital between 9 am and 4 pm and 23 March at the Jules Bordet Institute between 9 am and 4 pm.   
Health issues
Rare and complex epilepsies
Description Epilepsy is a chronic neurological disease. It is common, can first appear at any age and covers a very heterogeneous group of diseases with multiple causes. In one third of cases epileptic seizures continue despite medication (refractory epilepsy).  A considerable number of patients present a rare and distinct epileptic syndrome for which the prognosis for controlling the seizures and neurological development is poor. These rare epilepsies are for the most part of genetic origin. Rare and complex epilepsies affect almost 5 persons in every 10,000 of the population.  Treatment The Epileptology Clinic of the Erasmus Hospital and Queen Fabiola Children’s University Hospital (HUDERF) possesses specific expertise in treating complex epilepsies.  The centre is recognised by the INAMI/RIZIV [Belgian National Institute for Health and Disability Insurance] as an approved Belgian centre for the treatment of refractory epilepsies.  The rooms at our Epilepsy Exploration Unit ere specially equipped for prolonged video EEG monitoring. The Erasmus Hospital is specialised in intracranial EEG monitoring for the pre-surgery assessment of refractory epilepsies while the HUDERF is specialised in treating epilepsy in children. The multidisciplinary approach at the two sites permits a full range of diagnostic and treatment methods, from the latest medicines and ketogenic diet to surgery.   The H.U.B’s Rare Diseases Function provides access to leading edge  genetic diagnostic technologies that make it possible to identify a genetic cause in a large number of patients with rare and complex  epilepsies and thereby permit targeted treatment. Thanks to close cooperation with neuropaediatrics at the Erasmus Hospital and the HUDERF we are able to offer paediatric patients a structured transition to care in adulthood that is adapted specifically to the individual needs of each patient. Our multidisciplinary medical and paramedical care allows us to treat not only epilepsy but also the medical conditions that are often associated with epilepsy. Advice Genetic factors play an important role in epilepsy, especially if the epilepsy first appears in childhood or is associated with developmental disorders.  Specialised genetic testing is then indicated. Several hundred genes are associated with epilepsy. Identifying a genetic cause not only permits a precise diagnosis but also genetic advice, the prognosis and – increasingly frequently – precision treatment. For patients with refractory epilepsy, pre-surgery exploration can lead to a surgical solution (brain surgery, gamma knife, vagus nerve stimulation, deep brain stimulation, Laser Interstitial Thermal Therapy (LITT). Research Other areas of expertise and research activities:Prolonged EEG monitoring at the Intensive Care Unit to diagnose epileptic seizures in seriously ill patientsParticipation in pharmaceutical trials sponsored by the industry on the use of the latest drugsParticipation in research and expertise networks:Epinord (Franco-Belgian intracranial ’EEG expertise group)ERN EpiCARE (European Reference Network for Rare and Complex Epilepsies)The genetic research networks EpiGen, Epi25 and Consortium on Complex Epilepsies of the International League Against Epilepsy (ILAE)Critical Care EEG Monitoring Research Consortium(CCEMRC)  Documents and useful links Epileptology Clinic HUDERF Department of NeuropaediatricsEpilepsy Exploration UnitERN EpiCARE (European Reference Network for Rare and Complex Epilepsies)Epi25 NetworkConsortium on Complex Epilepsies of the International League Against Epilepsy (ILAE)Critical Care EEG Monitoring Research Consortium (CCEMRC)Patients’ associations: https://ligueepilepsie.behttps://www.epilepsieliga.be Our specialists Neurologists specialising in epilepsy: Prof. Chantal Depondt (Head of the Rare Neurological Diseases Clinic)Prof. Nicolas Gaspard (Head of the Department of Neurology)Dr. Benjamin Legros (Head of the Adult Epileptology Clinic and of the Reference Centre for the treatment of Refractory Epilepsy)Paediatricians specialising in epilepsy: Prof. Alec Aeby (Head of the Department of Neuropaediatrics)Dr. Tom Balfroid (Erasmus Hospital)Dr. Cynthia Prigogine (HUDERF)Dr. Claudine Sculier (Erasmus Hospital – Medical consultant at the Epilepsy Exploration Unit)Dr. Pauline Van Gyseghem (HUDERF)
Rare and complex epilepsies
Health issues
Rare diseases
Rare diseases function Patients with a rare disease must receive proper and specific care: a rapid diagnosis followed by treatment in care units with staff trained in these rare diseases. The mission of the Rare Diseases Function (8 in Belgium) is to coordinate, with teams with the required expertise, the care pathways and scientific research and training projects of all the professionals involved  in providing an adapted and constantly evolving care.  
Rare diseases
Article
Rare diseases: 8 questions to ask
Did you know that 8 questions asked to your patients can already guide you in the case of a rare disease? If you can answer most of these 8 questions with 'yes' and your intuition confirms it, it would be wise to consider a rare disease. Does the patient present with acute or chronic symptoms that are inexplicable, inconsistent or non-specific, or symptoms at an unusually young age? Is there a family history? Have there been a number of periods of illness with different or identical symptoms? Is there a history of consultations with different medical specialities without satisfactory results? Are there any pathological or borderline results that are inconclusive at first sight? Has there ever been any suspicion of psychosomatic aetiology? Have there been phases of the illness going back several years? Are certain exposure scenarios known (in relation to food, leisure activities, housing, animals, travel or work)? Do not hesitate to refer your patient to a health specialist or geneticist, preferably linked to one of our designated centres of expertise for rare diseases, who are better placed to make a diagnosis.  For more information, visit https://ulbgenetics.be/fonctions-maladies-rares/ * These 8 questions were written by rare disease experts involved in the EMRaDi project.
Health issues
Raynaud’s disease
What is Raynaud’s disease? Raynaud’s disease is a disorder that affects the blood circulation, principally in the fingers and toes but sometimes in the ears, nipples, knees or nose.  It is characterised by a vasospasm – sudden constrictions of the blood vessels that considerably reduce the blood flow to the extremities – most often triggered by an exposure to cold but also by emotional stress. It can exist as an isolated  condition (primary Raynaud’s disease), in which case it is observed more frequently in women and people living in colder climates. The exact cause of primary Raynaud’s disease is not known.      Raynaud’s disease also occurs in men and women with autoimmune diseases, diseases of the conjunctive tissue and also other diseases, most notably:  Systemic scleroderma  Disseminated lupus erythematosis Sjögren’s disease  Rheumatoid polyarthritis  Polymyositis  Pulmonary hypertension Buerger’s disease (thromboangiitis obliterans) In these cases one speaks of secondary Raynaud’s disease. What are the risk factors?  Although we don’t know why certain persons develop Raynaud’s disease, certain risk factors are known:  Pre-existing connective tissue Autoimmune disease Smoking Repetitive pressure exercised on the hands, by using vibrating tools for example (electric tools)  Injuries or traumas Exposure to chemical products Side effects of certain medicines (beta blockers)  Etc. Symptoms and diagnosis There are some very frequent symptoms encountered in Raynaud’s disease patients but each patient can experience different symptoms. The fingers and toes turn white, then blue – generally after having been exposed to cold air or cold objects, or after having suffered stress – and then turn red when warmed up again. In serious cases, sores develop at the ends of the fingers or toes. In rare cases the fingers or toes can become infected or gangrenous, requiring amputation in the absence of treatment.  How to diagnose Raynaud’s disease ? Patients in our medical clinic are initially assessed by a rheumatologist and, depending on the severity, they can also be examined by a vascular specialist.  A large part of the diagnosis will focus on assessing the symptoms. In addition to a complete medical history and a medical examination, our team will generally order at least one type of blood test. A patient may also undergo a cold provocation test to highlight the colour changes in the hands or feet. With secondary Raynaud’s disease it is also important to identify - and treat- the underlying autoimmune disease that may be at the origin of the Raynaud’s disease (for example systemic sclerodermia: see the Erasmus Hospital’s systemic sclerodermia reference centre).  An examination by capillaroscopy is carried out. This non-invasive and painless examination makes it possible to visualise the capillaries in the nail bed. In the case of secondary Raynaud’s disease, as in the case of systemic sclerodermia, a reduction in the number of capillaries is observed as well as  the presence of dilated capillaries.       Treatment After an in-depth evaluation the team of doctors will draw up a treatment plan based on the type and extent of the disease, the general health status of the patient and the patient’s preferences.   Although there is no cure for Raynaud’s disease, it can normally be managed with appropriate treatment, such as:  Lifestyle changes: Limit exposure to the cold by dressing warmly: gloves, socks, scarf, hat and several layers  Stop smoking to improve circulation and your health in general Avoid the use of vibrating tools. Medical treatment Alpha blockers suppress the response of the sympathetic nervous system that leads to vasoconstriction (narrowing of the blood vessels)  Other medicines improve the blood flow to the fingers and toes by dilating the blood vessels. These include  calcium channel inhibitors and phosphodiesterase  inhibitors. Avoid using beta blockers, generally used for treating high blood pressure and that slow the heart rate and reduce the blood flow to extremities For patients who do not show a sufficient response to the aforementioned medicines there can be experimental medicine options - medicines that can be used in clinical trials. 
Raynaud’s disease
Rich page
Red Blood Cell Day 2025
On Thursday 20 February 2025, the ‘Red Blood Cell’ group of the Belgian Haematology Society and the H.U.B. are organising the next Red Blood Cell Day. Discover the programme and the speakers.  Program & speakers This event will take place at the Jules Bordet Institute, Rue Meylemeersch 90, 1070 Anderlecht, in the Tagnon Auditorium, 1st FloorSession for healthcare professionals09h00Eosinophils and SCD : Bad couple ?S. Karimi (HUB - Brussels)09h30Sickle Cell NephropathyV. Labarque (KUL - Leuven)10h00Vaccination in SCD - What is a realistic approach ?M. Hoyoux (CHU Liège - Citadelle)10h30Coffee Break 10h50Immunological and Practical Aspects of Transfusion in HemoglobinopathiesV. Deneys (CUSL - UCL - Brussels)11h20Transfusional Optimization in Transfusion-Dependent ThalassemiaG. De Luna  (Henri Mondor -APHP - Paris)11h50HSCT in Hbpathies : New regimens versus new therapiesF. Bernaudin (CHIC - Paris)12h20Cerebrovascular workup in SCDB. Biemond (UMC - Amsterdam)13h00Lunch 14h00Diagnostic pitfalls and New Therapies in RBC EnzymopathiesF. Galacteros (Henri Mondor -APHP - Paris)14h30Clinical reesearch in remote region - Experience in DRCB. Mbiya (Centre Mashi - Mbujimayi)15h00Systemic racism vs Care : A sickle cell perspectiveM. Shema (UMF lasi)15h30Pain at Home - Evolution of pain after hospital dischargeL. Vinguetama-Périanagom (ULB - Brussels)16h00Alternatives to opioïd analgesiaC. Greco (Necker-Enfants Malades - APHP - Paris)16h30Coffee Break Session for patients16h45Non-opioid analgesicsS. Hatton (Necker-Enfants Malades - APHP - Paris)17h15NutritionV. Hannecart (HUB - Brussels) & K. Egberts DrepaCoach17h45Access to healthcare and the stay or return of sick peopleS. Jassogne & K. Vanhees - Medimmigrant asbl18h45End of the event  Inscription - Professionnels de santé Inscription - Patients En collaboration avec
Rich page
Request to modify your personal data
Please complete the form below to request a change to your personal data at the Brussels University Hospital. Personal data modification request form Patient's name Patient's first name Email address Telephone number National register identification number Please indicate below the information to be modified in your medical record. Please be as specific as possible.
Information
Requesting a second opinion
Why request a second opinion at the Erasmus Hospital? Above all else, requesting a second opinion is a choice. Everybody is entitled to request a second medical opinion for support and reassurance regarding their treatment.  Also, not all doctors and hospitals necessarily have the expertise, experience and/or equipment required to treat your pathology.   As a university hospital, the Erasmus Hospital gives pride of place to research and teaching and remains at the forefront of scientific research. As a result, when all conventional treatment options have been attempted, there sometimes remain possibilities at the Erasmus Hospital to benefit from innovative treatment in the framework of clinical trials.  What procedures to follow when requesting a second opinion? Whenever possible it is preferable to obtain a copy of your medical records from your GP. This is clearly important so that the Erasmus Hospital can give a second opinion on the basis of all the available information and not repeat examinations and visits unnecessarily.  Specifically, patients should request a complete copy of medical records  from their original doctor and/or hospital. These have a legal obligation to provide the patient with these records within 15 days or to send them to the doctor of the patient’s choice. Some information is shared between Belgian hospitals through Brussels Health Network for the exchange of medical information. Patients must give their written and signed permission to the hospitals involved in this exchange.  Image Contacting the Erasmus Hospital In practical terms, patients can contact the department of their choice depending on the problem encountered.   Services Together we are stronger. Requesting a second opinion is a way of taking a fresh look at your care options. So don’t hesitate to contact us for guidance on your care pathway.